Consensus report from the Food Allergy Research & Education (FARE) 2019 Oral Immunotherapy for Food Allergy Summit

Food allergy is a major health problem affecting 5% to 10% of the population in developed nations, including an estimated 32 million Americans. Despite the large number of patients suffering from food allergies, up until the end of January 2020, no treatment for food allergies had been approved by the US Food and Drug Administration. The only options were avoidance of food allergen triggers and acute management of allergic reactions. A  considerable body of data exists supporting oral immunotherapy (OIT) as a promising, novel treatment option, including that for the now Food and Drug Administration–approved peanut OIT product Palforzia (Aimmune Therapeutics, Brisbane, Calif).

Source: Journal of Allergy and Clinical Immunology - June 2, 2020 Category: Allergy & Immunology Authors: Amber N. Pepper, Amal Assa ’ad, Michael Blaiss, Emily Brown, Sharon Chinthrajah, Christina Ciaccio, Mary Beth Fasano, Ruchi Gupta, Nurry Hong, David Lang, Todd Mahr, Erin Malawer, Anita Roach, Wayne Shreffler, Scott Sicherer, Kathleen Vickers, Brian P. Source Type: research